Skip to main content

Biopharma Startups

Updated November 2026

Companies in the biopharma sector developing innovative solutions and technologies.

Explore 915 recently funded biopharma companies with verified founder contact information and fundraising data.

Total Companies
915
Total Funding
$745.2M
Avg Funding
$29.8M
Global Reach
8
countries

Top Cities for Biopharma

Milan
Santiago De Compostela
Rockville
Oxford
Cambridge
Copenhagen

Recently Funded Companies

Export
Milan, Italy

Bio4Dreams is a privately funded certified incubator for innovative startups in very early stage phase, dedicated to Life Sciences.

$2.8M raised
Apr 2023

Founder Contacts

41,000+ verified contacts

Santiago De Compostela, Spain

Addressing “undruggable intracellular targets” in oncology

Apr 2023

Founder Contacts

41,000+ verified contacts

Rockville, United States

NeuroCytonix is a biomedical technology company that is centered on tissue creation and regeneration.

$4.0M raised
Apr 2023

Founder Contacts

41,000+ verified contacts

Oxford, United Kingdom

Oxford Cancer is developing and commercialising a suite of colorectal cancer biomarker tests to improve the current treatment pathway.

Apr 2023

Founder Contacts

41,000+ verified contacts

Cambridge, United States

Flare Therapeutics is a biotech startup that creates precision therapies for cancer and other disorders by targeting transcription factors.

$123.0M raised
Mar 2023

Founder Contacts

41,000+ verified contacts

Cambridge, United Kingdom

Providing tools to physicians in the treatment of patients with immune-mediated disease, through prediction of long term clinical prognosis.

Mar 2023

Founder Contacts

41,000+ verified contacts

Copenhagen, Denmark

MELLO develops probiotic delivery technology to enhance the effective delivery of probiotics.

Mar 2023

Founder Contacts

41,000+ verified contacts

Barcelona, Spain

Nuage Therapeutics engages in developing drugs which target proteins in disordered regions for challenging indications faced by patients.

$12.9M raised
Mar 2023

Founder Contacts

41,000+ verified contacts

Princeton, United States

NJ Bio provides chemistry and biology services to clients from the biotech and pharmaceutical sectors.

$5.6M raised
Mar 2023

Founder Contacts

41,000+ verified contacts

Paris, France

Enabling tomorrow's therapies manufacturing for today's patients, with sound

$2.8M raised
Mar 2023

Founder Contacts

41,000+ verified contacts

Copenhagen, Denmark

Amplify Therapeutics is dedicated to the development of transformative, disease-modifying therapies for Gaucher disease.

$533K raised
Mar 2023

Founder Contacts

41,000+ verified contacts

Pittsburgh, United States

Shaping the Future of Spatially Intelligent Biology

Feb 2023

Founder Contacts

41,000+ verified contacts

Glasgow, United Kingdom

Causeway Therapeutics is a clinical-stage biopharmaceutical company specializing in musculoskeletal health.

$10.5M raised
Feb 2023

Founder Contacts

41,000+ verified contacts

Lidingö, Sweden

This company is a Swedish medical technology company focused on improving the diagnosis and treatment of breast cancer.

$1.3M raised
Feb 2023

Founder Contacts

41,000+ verified contacts

Boston, United States

Aera Therapeutics is a biotechnology firm that employs its own protein nanoparticle (PNP) delivery platform.

$193.0M raised
Feb 2023

Founder Contacts

41,000+ verified contacts

Boston, United States

Alloplex Biotherapeutics develops a cellular therapeutic platform for treating cancer.

$20.0M raised
Feb 2023

Founder Contacts

41,000+ verified contacts

Hamilton, Canada

Fusion Pharmaceuticals is a clinical-stage oncology company focused on developing radiopharmaceuticals.

$60.0M raised
Feb 2023

Founder Contacts

41,000+ verified contacts

Newyork, United Kingdom

Lirum Therapeutics is an innovative biopharmaceutical company focused on the treatment of debilitating diseases.

$7.0M raised
Feb 2023

Founder Contacts

41,000+ verified contacts

Wilmington, United States

Eolo Pharma focuses on developing drugs targeting the molecular and cellular basis of inflammation-related diseases.

$1.8M raised
Feb 2023

Founder Contacts

41,000+ verified contacts

Little Chesterford, United Kingdom

Evonetix is a provider of a desktop platform designed to synthesize DNA at unprecedented accuracy and scale.

$24.1M raised
Feb 2023

Founder Contacts

41,000+ verified contacts

Saint Priest, France

Advanced BioDesign as an immunotechnology specialist, provides a tailored and high value solution.

$15.6M raised
Feb 2023

Founder Contacts

41,000+ verified contacts

New York, United States

Roivant Sciences is a biopharmaceutical company focused on the development of medicines and healthcare technologies to patients.

$230.0M raised
Feb 2023

Founder Contacts

41,000+ verified contacts

San Francisco, United States

Michroma is a fungal biofactories to produce the next generation of ingredients.

$6.4M raised
Feb 2023

Founder Contacts

41,000+ verified contacts

San Carlos, United States

Apexigen is a clinical-stage biopharmaceutical company focused on discovering and developing a new antibody therapeutics for oncology.

$2.8M raised
Jan 2023

Founder Contacts

41,000+ verified contacts

Boston, United States

EIP Pharma is a clinical stage therapeutics company developing drugs to treat neurodegenerative diseases.

$21.0M raised
Jan 2023

Founder Contacts

41,000+ verified contacts

Showing 726 to 750 of 915 companies

About the Biopharma Startup Ecosystem

The biopharma sector is an active area of startup innovation and venture capital investment. Companies in this space are developing new technologies, platforms, and services that address evolving market needs and create new business opportunities.

Funding Trends in Biopharma

Biopharma companies raise capital across various funding stages, from early seed rounds to late-stage growth financing. Investor interest in this sector is driven by the size of the addressable market, the pace of technology adoption, and the potential for scalable business models.

Growth Outlook

The biopharma sector is expected to continue evolving as technology advances, market dynamics shift, and new opportunities emerge. Companies that demonstrate strong product-market fit, efficient growth, and clear competitive advantages are well-positioned to attract continued investment.

Biopharma Funding Breakdown

Here is how funding is distributed among the 915 biopharma companies tracked in the VCBacked database.

Average Funding
$29.8M
Total Funding Tracked
$745.2M
Countries Represented
8

Distribution by Funding Stage

Other25 companies

Top Cities for Biopharma

1.Boston
3 companies$234.0M
2.Cambridge
2 companies$123.0M
3.Copenhagen
2 companies$533K
4.Milan
1 companies$2.8M
5.Santiago De Compostela
1 companiesUndisclosed

Related Industries

Companies in the biopharma sector often overlap with or complement businesses in adjacent industries. Exploring related verticals can help you discover additional companies, identify partnership opportunities, and understand the broader competitive landscape.

Ready to Connect with Biopharma Startups?

Perfect for: B2B sales teams targeting biopharma companies, investors exploring sector opportunities, and service providers looking for funded companies ready to scale.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked